CAJ | 학술논문

经导管封堵术主要用于治疗先天性心脏病间隔缺损，也用于其他心内或心外异常分流，如瓣膜置换术后瓣周漏。封堵器植入后感染性心内膜炎（IE）非常罕见，资料较完整者仅有18例报道，但是一旦发生则非常严重，随着经皮封堵装置临床应用的日益广泛，该类并发症须引起足够重视，甚至对封堵术前、术中及术后预防性应用抗生素方案也可能需要重新评价。本文对封堵器植入后IE的初步认识及诊治进展进行综述。
경도관봉도술주요용우치료선천성심장병간격결손，야용우기타심내혹심외이상분류，여판막치환술후판주루。봉도기식입후감염성심내막염（IE）비상한견，자료교완정자부유18례보도，단시일단발생칙비상엄중，수착경피봉도장치림상응용적일익엄범，해류병발증수인기족구중시，심지대봉도술전、술중급술후예방성응용항생소방안야가능수요중신평개。본문대봉도기식입후IE적초보인식급진치진전진행종술。
The percutaneous approach remains an increasingly utilization and valuable method of treating congenital heart disease (CHD) and perivalvular leak. Although reportedly rare, infective endocarditis (IE) as a complication may become more widely recognized as the use of percutaneous occluder devices increases and the population of patients with indwelling prostheses grows. Eighteen previous cases of IE after occluder device implantation have been reported. The increasing use of intracardiac devices may require a reevaluation of the possible need for administration of prophylactic antibiotics before, during, or after the procedure and the type of antibiotics to be given. The current knowledge of occluder device-associated IE was reviewed in this article.